Atlas Trials

A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers

Clinical trial NCT05007275 · UNKNOWN

Trial details

NCT number
NCT05007275
Sponsor
Imperial College London
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Covid19SARS-CoV-2 Infection
Start date
2021-10-10
Primary completion
2024-06-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.